Recently, the topic of weight-loss drugs has been extremely popular. Last week, the stock price of Pharmaceutical company Novo Nordisk (NVO) increased by 10% within a week because its weight loss drug Ozempic showed therapeutic effects on chronic kidney failure in diabetic patients during trials.
As public interest in weight loss drugs continues to increase, it may bring some chain reactions to the capital market... Let's take a look at the la...

Spoiler: At the end of this post, there is a chance for you to win points! Happy Friday, mooers! Welcome back to Weekly Buzz, where we review the news, performance, and community sentiment of the selected buzzing stocks on moomoo platform based on search and message volumes of this week! (Nano caps are excluded.)
Pick Your Choice:
Buzzing Stocks List & Mooers Comments
After sudden conflict in the Middle East, ...

hello Everyone